BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 1963529)

  • 1. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae.
    Papanicolaou GA; Medeiros AA; Jacoby GA
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2200-9. PubMed ID: 1963529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of a new plasmid-encoded SHV-type beta-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae.
    Podbielski A; Schönling J; Melzer B; Warnatz K; Leusch HG
    J Gen Microbiol; 1991 Mar; 137(3):569-78. PubMed ID: 2033379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae.
    Tzouvelekis LS; Tzelepi E; Mentis AF; Tsakris A
    J Antimicrob Chemother; 1993 May; 31(5):645-54. PubMed ID: 8335495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
    Bradford PA; Urban C; Mariano N; Projan SJ; Rahal JJ; Bush K
    Antimicrob Agents Chemother; 1997 Mar; 41(3):563-9. PubMed ID: 9055993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins.
    Arlet G; Rouveau M; Fournier G; Lagrange PH; Philippon A
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2020-3. PubMed ID: 8239625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmid-mediated AmpC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta-lactams, including moxalactam.
    Horii T; Arakawa Y; Ohta M; Ichiyama S; Wacharotayankun R; Kato N
    Antimicrob Agents Chemother; 1993 May; 37(5):984-90. PubMed ID: 8517725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
    Shi WF; Zhou J; Qin JP
    Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of plasmid mediated AmpC beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolated from blood cultures].
    Sarı AN; Biçmen M; Gülay Z
    Mikrobiyol Bul; 2013 Oct; 47(4):582-91. PubMed ID: 24237427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
    Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.
    Paul GC; Gerbaud G; Bure A; Philippon AM; Pangon B; Courvalin P
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1958-63. PubMed ID: 2692515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasmid-mediated cephalosporinase among extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae].
    Wang QT; Liu YM; Wang H; Sun HL; Chen MJ; Du XL
    Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):487-90. PubMed ID: 15312399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.
    Ishii Y; Ohno A; Taguchi H; Imajo S; Ishiguro M; Matsuzawa H
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2269-75. PubMed ID: 8619581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.
    Alvarez M; Tran JH; Chow N; Jacoby GA
    Antimicrob Agents Chemother; 2004 Feb; 48(2):533-7. PubMed ID: 14742206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China.
    Ding H; Yang Y; Lu Q; Wang Y; Chen Y; Deng L; Wang A; Deng Q; Zhang H; Wang C; Liu L; Xu X; Wang L; Shen X
    Eur J Clin Microbiol Infect Dis; 2008 Oct; 27(10):915-21. PubMed ID: 18449580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli.
    Nordmann P; Mariotte S; Naas T; Labia R; Nicolas MH
    Antimicrob Agents Chemother; 1993 May; 37(5):939-46. PubMed ID: 8517720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.
    Poirel L; Le Thomas I; Naas T; Karim A; Nordmann P
    Antimicrob Agents Chemother; 2000 Mar; 44(3):622-32. PubMed ID: 10681329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece.
    Vatopoulos AC; Philippon A; Tzouvelekis LS; Komninou Z; Legakis NJ
    J Antimicrob Chemother; 1990 Nov; 26(5):635-48. PubMed ID: 2079446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.